Watched the presentation today from Professor Robyn Guymer and was very impressed. We are very lucky to have Prof. Guymer leading the upcoming 2RT trial which looks very promising. She mentioned she had approached 32 centres across 3 countries to be part of the trial and so far had had no refusals. This is very exciting that these Ophthalmology centres who are leaders in their geographic areas all want to be part of the trial because of the potential they can see in the treatment, based on the LEAD trial results.
Ann: 2RT Webinar Professor Robyn H Guymer MMBBS, PHD, page-4
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $51.48M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.8¢ | $137.7K | 624.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27766 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 34529 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.0¢ |
Change
0.010 ( 2.33 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 22.5¢ | 21.5¢ | 190801 | ||
| Last updated 15.47pm 14/06/2024 ? | |||||
| EYE (ASX) Chart |